PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
11-Nov-2024 Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates AccessWire
11-Nov-2024 First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial AccessWire
11-Nov-2024 Ainos Announces IRB Approval for Sjögren’s Syndrome Clinical Study at Shuang Ho Hospital, Affiliated with Taipei Medical University, and Plans to Initiate New Phase of Treatment Evaluation in Q1 2025 AccessWire
11-Nov-2024 Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference AccessWire
11-Nov-2024 Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference AccessWire
11-Nov-2024 Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers Gilead Sciences Ltd.
11-Nov-2024 InnoScot Health innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS Scotland InnoScot Health
11-Nov-2024 SMC recommends Yselty®▼ (linzagolix) for treating moderate to severe symptoms of uterine fibroids in adult women of reproductive age Theramex
11-Nov-2024 STORM Therapeutics Presents New Clinical Data on its First-in-Class METTL3 Inhibitor STC-15 at SITC 2024 STORM Therapeutics
11-Nov-2024 Resolution Therapeutics Announces New Clinical and Preclinical Data Showcasing Regenerative Macrophage Therapy at AASLD The Liver Meeting® 2024 to Support the Ongoing Phase 1/2 Study for RTX001 in End-Stage Liver Disease Resolution Therapeutics
11-Nov-2024 Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) Autolus Therapeutics
11-Nov-2024 Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma Johnson & Johnson
11-Nov-2024 AstraZeneca and Amgen’s Tezspire meets both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps AstraZeneca
11-Nov-2024 ACG Inspection launches Life Sciences Cloud ACG Inspection
11-Nov-2024 Moberg Pharma’s Nomination Committee appointed Moberg Pharma
11-Nov-2024 Transgene Reports Business, Pipeline and Financial Update for Q3 2024 Transgene
11-Nov-2024 Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Transgene
11-Nov-2024 Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board Ebenbuild
11-Nov-2024 Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients AccessWire
11-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces Institutional Investment AccessWire